VADAKKE PUTHIYOTTIL, S.; EDAYATTIL, A.; N K, S. Pathologic Response to Neoadjuvant Subcutaneous Fixed-Dose Pertuzumab–Trastuzumab (Phesgo®) and Chemotherapy in HER2-Positive Locally Advanced Breast Cancer: A Case Series and Literature Review. Asian Pacific Journal of Cancer Care, v. 11, n. 3, p. 481-488, 2 maio 2026.